Title : Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease.

Pub. Date : 2001 Jan

PMID : 11234910






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: The objective of this study was to identify the relation between the cognitive benefit seen with the cholinesterase inhibitor metrifonate and changes in brain metabolism as visualized with [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET). Fluorine-18 butyrylcholinesterase Homo sapiens